Pharming Group NV
AEX:PHARM

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
AEX:PHARM
Watchlist
Price: 1.612 EUR 6.68% Market Closed
Market Cap: 1.1B EUR

Intrinsic Value

The intrinsic value of one PHARM stock under the Base Case scenario is hidden EUR. Compared to the current market price of 1.612 EUR, Pharming Group NV is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

PHARM Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
Pharming Group NV

Intrinsic Value History
Dive into the past to invest in the future

PHARM looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether PHARM usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about PHARM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PHARM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Pharming Group NV.

Explain Valuation
Compare PHARM to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about PHARM?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Pharming Group NV

Current Assets 277.6m
Cash & Short-Term Investments 166.2m
Receivables 43.6m
Other Current Assets 67.8m
Non-Current Assets 196.2m
Long-Term Investments 6.7m
PP&E 25m
Intangibles 134.9m
Other Non-Current Assets 29.6m
Current Liabilities 87.9m
Accounts Payable 78.2m
Other Current Liabilities 9.7m
Non-Current Liabilities 121.2m
Long-Term Debt 121.2m
Other Non-Current Liabilities -1k
Efficiency

Free Cash Flow Analysis
Pharming Group NV

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Pharming Group NV

Revenue
362.3m USD
Cost of Revenue
-36.6m USD
Gross Profit
325.7m USD
Operating Expenses
-289.3m USD
Operating Income
36.4m USD
Other Expenses
-36m USD
Net Income
383k USD
Fundamental Scores

PHARM Profitability Score
Profitability Due Diligence

Pharming Group NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Operating Margin is Increasing
Healthy Operating Margin
hidden
Profitability
Score

Pharming Group NV's profitability score is hidden . The higher the profitability score, the more profitable the company is.

PHARM Solvency Score
Solvency Due Diligence

Pharming Group NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Pharming Group NV's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

PHARM Price Targets Summary
Pharming Group NV

Wall Street analysts forecast PHARM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHARM is 2.091 EUR with a low forecast of 1.717 EUR and a high forecast of 2.573 EUR.

Lowest
Price Target
1.717 EUR
7% Upside
Average
Price Target
2.091 EUR
30% Upside
Highest
Price Target
2.573 EUR
60% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Pharming Group NV
does not pay dividends
Shareholder Yield

Current shareholder yield for PHARM is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one PHARM stock?

The intrinsic value of one PHARM stock under the Base Case scenario is hidden EUR.

Is PHARM stock undervalued or overvalued?

Compared to the current market price of 1.612 EUR, Pharming Group NV is hidden .

Back to Top